Amylyx Pharmaceuticals (AMLX) Asset Utilization Ratio (2022 - 2025)

Amylyx Pharmaceuticals' Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.0 for Q3 2025.

• In Q3 2025, Asset Utilization Ratio fell 100.42% year-over-year to 0.0; the TTM figure through Sep 2025 stood at 0.0 (down 100.42% YoY), while the FY2024 annual figure was 0.25, down 70.67% from the prior year.
• Asset Utilization Ratio was 0.0 for Q3 2025 at Amylyx Pharmaceuticals, down from 0.0 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.8 in Q1 2024 to a low of 0.0 in Q3 2025.
• Historically, Asset Utilization Ratio has averaged 0.4 across 4 years, with a median of 0.45 in 2024.
• The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio soared 860.92% in 2023, then slumped 100.42% in 2025.
• A 4-year view of Asset Utilization Ratio shows it stood at 0.08 in 2022, then jumped by 860.92% to 0.76 in 2023, then plunged by 46.71% to 0.4 in 2024, then plunged by 100.59% to 0.0 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.0 (Q3 2025), 0.0 (Q2 2025), and 0.0 (Q1 2025), per Business Quant data.